Home/Filings/4/0001062993-23-018421
4//SEC Filing

Lapidus Stanley 4

Accession 0001062993-23-018421

CIK 0001799011other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 6:39 PM ET

Size

7.7 KB

Accession

0001062993-23-018421

Insider Transaction Report

Form 4
Period: 2023-09-20
Transactions
  • Sale

    Common stock

    2023-09-20$1.45/sh3,405$4,937132,051 total
  • Sale

    Common stock

    2023-09-21$1.44/sh100$144131,539 total
  • Sale

    Common stock

    2023-09-20$1.44/sh412$593131,639 total
Footnotes (2)
  • [F1]Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
  • [F2]Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.

Issuer

Lucid Diagnostics Inc.

CIK 0001799011

Entity typeother

Related Parties

1
  • filerCIK 0001678195

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 6:39 PM ET
Size
7.7 KB